Literature DB >> 1711350

Two alpha-herpesvirus strains are transported differentially in the rodent visual system.

J P Card1, M E Whealy, A K Robbins, R Y Moore, L W Enquist.   

Abstract

Uptake and transneuronal passage of wild-type and attenuated strains of a swine alpha-herpesvirus (pseudorabies [PRV]) were examined in rat visual projections. Both strains of virus infected subpopulations of retinal ganglion cells and passed transneuronally to infect retino-recipient neurons in the forebrain. However, the location of infected forebrain neurons varied with the strain of virus. Intravitreal injection of wild-type virus produced two temporally separated waves of infection that eventually reached all known retino-recipient regions of the central neuraxis. By contrast, the attenuated strain of PRV selectively infected a functionally distinct subset of retinal ganglion cells with restricted central projections. The data indicate that projection-specific groups of ganglion cells are differentially susceptible to the two strains of virus and suggest that this sensitivity may be receptor mediated.

Entities:  

Mesh:

Year:  1991        PMID: 1711350     DOI: 10.1016/0896-6273(91)90236-s

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  76 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.

Authors:  G A Smith; L W Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Intravitreal injection of the attenuated pseudorabies virus PRV Bartha results in infection of the hamster suprachiasmatic nucleus only by retrograde transsynaptic transport via autonomic circuits.

Authors:  Gary E Pickard; Cynthia A Smeraski; Christine C Tomlinson; Bruce W Banfield; Jessica Kaufman; Christine L Wilcox; Lynn W Enquist; Patricia J Sollars
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  Transneuronal labeling of a nociceptive pathway, the spino-(trigemino-)parabrachio-amygdaloid, in the rat.

Authors:  L Jasmin; A R Burkey; J P Card; A I Basbaum
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 5.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

6.  Redistribution of cellular and herpes simplex virus proteins from the trans-golgi network to cell junctions without enveloped capsids.

Authors:  Todd W Wisner; David C Johnson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Cytomegalovirus cell tropism, replication, and gene transfer in brain.

Authors:  A N van Den Pol; E Mocarski; N Saederup; J Vieira; T J Meier
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

8.  Structure-function analysis of the gE-gI complex of feline herpesvirus: mapping of gI domains required for gE-gI interaction, intracellular transport, and cell-to-cell spread.

Authors:  J D Mijnes; B C Lutters; A C Vlot; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors.

Authors:  Katarina Polcicova; Kim Goldsmith; Barb L Rainish; Todd W Wisner; David C Johnson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Complementation analysis of pseudorabies virus gE and gI mutants in retinal ganglion cell neurotropism.

Authors:  L W Enquist; J Dubin; M E Whealy; J P Card
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.